Editor's Choice
The missing data that cost $20bn
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g2695 (Published 10 April 2014) Cite this as: BMJ 2014;348:g2695
Related articles
- News Published: 07 April 2014; BMJ 348 doi:10.1136/bmj.g2632
- Research Published: 09 April 2014; BMJ 348 doi:10.1136/bmj.g2547
- Research Published: 09 April 2014; BMJ 348 doi:10.1136/bmj.g2545
- News Published: 03 April 2014; BMJ 348 doi:10.1136/bmj.g2579
- Editorial Published: 09 April 2014; BMJ 348 doi:10.1136/bmj.g2548
- Letter Published: 09 July 2014; BMJ 349 doi:10.1136/bmj.g4130
- Correction Published: 20 February 2015; BMJ 350 doi:10.1136/bmj.h1007
See more
- Infectious disease: UKHSA finds stark health inequalities in England’s hospital admissionsBMJ May 02, 2025, 389 r893; DOI: https://doi.org/10.1136/bmj.r893
- Moderna could be expelled from ABPI after breaching rules over covid vaccine trialBMJ May 02, 2025, 389 r889; DOI: https://doi.org/10.1136/bmj.r889
- UKHSA warns of low level resistance against new antibioticBMJ April 30, 2025, 389 r868; DOI: https://doi.org/10.1136/bmj.r868
- Malaria is poised for a devastating comeback in Africa’s “worst moment in 25 years”BMJ April 25, 2025, 389 r783; DOI: https://doi.org/10.1136/bmj.r783
- Vaccine preventable diseases are making “dangerous comeback,” health leaders warnBMJ April 25, 2025, 389 r823; DOI: https://doi.org/10.1136/bmj.r823
Cited by...
- Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC4 E): the ALIC4 E protocol
- Statin wars: have we been misled about the evidence? A narrative review
- Concerns about the latest NICE draft guidance on statins
- The pioneers of transparency